Anke Niedernberg

Anke Niedernberg is the SVP & Head of the Transformation Office at Advanz Pharma. Anke has held various positions at Sandoz, including eHealth Lead Sandoz Germany, Head Global Pipeline Portfolio, Head Global Portfolio Management ad interim, and Member of the Hexal Supervisory Board. Anke was also the Head Global Launch Management and Head SDC Strategy Planning. Prior to their work at Sandoz, they were an Associate at HgCapital and a Project Manager at McKinsey.

They work with Adeel Ahmad - Chief Financial Officer, Nick Warwick - Chief Medical Officer, and Robert Sully - General Counsel. Anke Niedernberg reports to Graeme Duncan, Chief Executive Officer.